638 results match your criteria: "centre hospitalier regional universitaire de Lille[Affiliation]"
Encephale
April 2019
Clinique de psychiatrie, hôpital Fontan), unité CURE, centre hospitalier régional universitaire de Lille (CHRU de Lille), 2, avenue Oscar-Lambret, 59000 Lille, France; Laboratoire de sciences cognitives et sciences affectives (SCALab-PsyCHIC), CNRS UMR 9193, université de Lille, 59000 Lille, France.
Objectives: The UHSA (UHSA) are French psychiatric units for inmates which admit detainees suffering from a psychiatric disorder requiring full-time hospital care. Non-psychiatric pathologies are overrepresented in patients with psychiatric disorders but also in detainees. As a result, patients hospitalized in UHSA are largely exposed to non-psychiatric conditions, and exploring the organization of general medical care for these patients appears very relevant.
View Article and Find Full Text PDFOphthalmic Plast Reconstr Surg
September 2018
Division of Maxillofacial Surgery, Department of Surgery, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Extensive midface and orbital reconstruction is challenging, especially in a pediatric population. A 13-year-old patient was diagnosed with fibrous dysplasia of the midface, which required complete resection of the zygomatic bone and orbital floor. The authors present a complete midface and orbital reconstruction, using a patient-specific autologous bone graft, in a growing pediatric patient.
View Article and Find Full Text PDFBlood
October 2018
Haematology Department, Centre Hospitalier Universitaire Rennes, Rennes, France.
Obinutuzumab is a type II anti-CD20 monoclonal antibody that enhances antibody-dependent cellular cytotoxicity better than rituximab. Given promising results with lenalidomide and rituximab, this phase 1b study assessed the safety and efficacy of lenalidomide combined with obinutuzumab (GALEN). Patients age ≥18 years with relapsed or refractory (R/R) follicular lymphoma (FL) after rituximab-containing therapy received escalating doses (10 [n = 7], 15 [n = 3], 20 [n = 6], and 25 mg [n = 3]) of daily oral lenalidomide on days 1 to 21 of cycle 1 and on days 2 to 22 of cycles 2 to 6 (28-day cycles).
View Article and Find Full Text PDFN Engl J Med
July 2018
Centre Hospitalier Régional Universitaire de Lille, Lille, France
Orthop Traumatol Surg Res
February 2019
Université de Lille Nord de France, 59037 Lille, France; Service d'orthopédie, hôpital Roger-Salengro, centre hospitalier régional universitaire de Lille, place de Verdun, 59037 Lille, France.
Patellar complications are a source of poor total knee arthroplasty (TKA) outcomes that can require re-operation or prosthetic revision. Complications can occur with or without patellar resurfacing. The objective of this work is to answer six questions.
View Article and Find Full Text PDFWorld J Urol
March 2019
Department of Urology, University of Minnesota, Minneapolis, MN, USA.
Objectives: Recent advances have led to the use of magnetic resonance imaging (MRI) alone or with fusion to transrectal ultrasound (TRUS) images for guiding biopsy of the prostate. Our group sought to develop consensus recommendations regarding MRI-guided prostate biopsy based on currently available literature and expert opinion.
Methods: The published literature on the subject of MRI-guided prostate biopsy was reviewed using standard search terms and synthesized and analyzed by four different subgroups from among the authors.
BJOG
January 2019
Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.
Objective: To develop core outcome sets (COS) for studies evaluating interventions for (1) prevention and (2) treatment of postpartum haemorrhage (PPH), and recommendations on how to report the COS.
Design: A two-round Delphi survey and face-to-face meeting.
Population: Healthcare professionals and women's representatives.
Lancet Oncol
July 2018
Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Osaka, Japan.
Background: Immune checkpoint blockade therapy has shown promising results in patients with advanced hepatocellular carcinoma. We aimed to assess the efficacy and safety of pembrolizumab in this patient population.
Methods: KEYNOTE-224 is a non-randomised, multicentre, open-label, phase 2 trial that is set in 47 medical centres and hospitals across ten countries.
BMJ Case Rep
June 2018
Pediatric and AYA oncology Unit, oscar lambret center, lille, France.
We report the case of a 15-year-old female patient suffering from progressive anorexia, weight loss and recurrent abdominal pain, initially diagnosed as anorexia nervosa. She eventually presented with severe malnutrition and acute bowel obstruction, revealing a mass of the transverse colon. A well-differentiated Lieberkühn adenocarcinoma was established by histology.
View Article and Find Full Text PDFN Engl J Med
June 2018
From the National and Kapodistrian University of Athens School of Medicine, Athens (M.A.D., E.K.); ASST Grande Ospedale Metropolitano Niguarda, Milan (A.T.), and Città della Salute Hospital and University, Turin (L.O.) - both in Italy; Concord Hospital, University of Sydney, Concord, NSW (J.T.), and Peter MacCallum Cancer Centre and St. Vincent's Hospital, Melbourne, VIC (C.T.) - both in Australia; Hospital Universitario de Salamanca, Salamanca, Spain (R.G.-S.); Ottawa Hospital, University of Ottawa, Ottawa (D.M.), and Royal Victoria Hospital at McGill University Health Centre, Montreal (C.S.) - both in Canada; Département d'Hématologie, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Paris (V.L.), Centre Hospitalier Universitaire de Nantes, Nantes (B.M.), and Centre Hospitalier Régional Universitaire de Lille, Institute of Hematolog-Tranfusion, Lille (C.H.) - all in France; Memorial Sloan Kettering Cancer Center, New York (M.L.P.); Colorado Blood Cancer Institute, Denver (J.V.M.); Dana-Farber Cancer Institute, Boston (S.P.T.); Pharmacyclics, Sunnyvale, CA (J.L., Z.S., T.G.); and Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany (C.B.).
Background: Single-agent ibrutinib has shown substantial activity in patients with relapsed Waldenström's macroglobulinemia, a rare form of B-cell lymphoma. We evaluated the effect of adding ibrutinib to rituximab in patients with this disease, both in those who had not received previous treatment and in those with disease recurrence.
Methods: We randomly assigned 150 symptomatic patients to receive ibrutinib plus rituximab or placebo plus rituximab.
A A Pract
October 2018
Department of Anesthesiology, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
We report for the first time the anesthetic management of 2 sisters suffering from neonatal ichthyosis and sclerosing cholangitis syndrome. They both presented with neonatal cholestatic jaundice and ichthyosis. The first was admitted for orthotopic liver transplantation at the age of 1 year, and the second patient underwent open pyeloplasty for a pyeloureteric junction syndrome at the age of 4 years.
View Article and Find Full Text PDFSpine J
December 2018
Department of Neurosurgery, OLV Ziekenhuis, Moorselbaan 164, 9300, Aalst, Belgium.
Background Context: Patients with large annular defects after lumbar discectomy for disc herniation are at high risk of symptomatic recurrence and reoperation.
Purpose: The present study aimed to determine whether a bone-anchored annular closure device, in addition to lumbar microdiscectomy, resulted in lower reherniation and reoperation rates plus increased overall success compared with lumbar microdiscectomy alone.
Design: This is a multicenter, randomized superiority study.
Blood
July 2018
Division of Hematology, University of Colorado, Aurora, CO.
PD-1 blockade is an effective therapy in relapsed/refractory (R/R) classical Hodgkin Lymphoma (cHL) who have relapsed after or are ineligible for autologous hematopoietic cell transplantation (HCT). Although single-agent anti-PD-1 monoclonal antibodies (mAb's) are associated with high response rates and durable remissions, available results to date suggest that a large majority of patients will eventually progress on therapy. Many of these patients are potential candidates for allogeneic HCT (allo-HCT) after receiving anti-PD-1 mAb's, and allo-HCT remains for now the only treatment with demonstrated curative potential in this setting.
View Article and Find Full Text PDFPediatrics
May 2018
Laboratoire de Virologie EA3610, University Lille and Faculté de Médecine, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Pityriasis rosea (PR) usually presents as acute exanthema with oval erythematous-squamous lesions localized on the trunk, arms, and legs with spontaneous remission. We present an unusual case of PR with frequent relapses during a period of 7 years. An 11-year-old white female patient presented with many pruritic erythematous oval lesions on her trunk.
View Article and Find Full Text PDFHaemophilia
July 2018
Centre de Biologie Pathologie Est, Service d'Hématologie Biologique, Groupe Hospitalier Est, Hospices Civils de Lyon, Bron, France.
Introduction: Haemophilia A (HA) and haemophilia B (HB) are X-linked recessive diseases, caused by a large number of pathogenic variants in the F8 and F9 genes. With the exception of introns 22 and 1 inversions which are frequent in severe HA cases, about 2000 unique variants in F8 and 1000 in F9 have been described in databases and their recurrence remains limited.
Aim And Methods: During routine analysis, we identified two recurrent missense variants, the F8 gene c.
Medicine (Baltimore)
April 2018
Service de Médecine et Chirurgie Pédiatrique, Centre Hospitalier de Cayenne, Rue des flamboyants, Cayenne Cedex, Guyane Française Université de Lille, UFR Médecine CHU Lille, Infection Control EA 7366, Pseudomonas aeruginosa Host-Pathogen Translational Research Group, Lille Département des centres délocalisés de prévention et de soins, Rue des flamboyants, Cayenne Cedex, Guyane Française Service de maladies infctieueses et du voyageur, Centre Hospitalier de Tourcoing-Hôpital Gustave Dron - 135, Tourcoing Département de l'information médicale, Centre Hospitalier de l'Ouest Guyane "Franck Joly"16 avenue du Général de Gaulle, Saint-Laurent-du-Maroni Département de l'information médicale, Centre Médico-chirurgical de Kourou, Kourou Département de l'information médicale, Centre Hospitalier de Cayenne, Rue des flamboyants, Cayenne Cedex, Guyane Française Service de Réanimation Médicale et Médecine Hyperbare, Hôpital Albert Calmette, Lille Cedex Service de néphrologie Service de urgences -SAMU Service de réanimation polyvalente, Centre Hospitalier de Cayenne, Rue des flamboyants, Cayenne Cedex, Guyane Française Centre anti pison, Centre Hospitalier Régional Universitaire de Lille, 2, Lille Cedex, France.
Am J Physiol Lung Cell Mol Physiol
July 2018
Perinatal Environment and Health, UPRES EA 4489, Université de Lille, Centre Hospitalier Régional Universitaire de Lille, Lille , France.
Pulmonary hypertension (PH) and right ventricular hypertrophy (RVH) affect 16-25% of premature infants with bronchopulmonary dysplasia (BPD), contributing significantly to perinatal morbidity and mortality. Omega-3 polyunsaturated fatty acids (PUFA ω-3) can improve vascular remodeling, angiogenesis, and inflammation under pathophysiological conditions. However, the effects of PUFA ω-3 supplementation in BPD-associated PH are unknown.
View Article and Find Full Text PDFWiedemann-Steiner syndrome (WSS) is a rare syndromic condition in which intellectual disability (ID) is associated with hypertrichosis cubiti, short stature, and characteristic facies. Following the identification of the causative gene (KMT2A) in 2012, only 31 cases of WSS have been described precisely in the literature. We report on 33 French individuals with a KMT2A mutation confirmed by targeted gene sequencing, high-throughput sequencing or exome sequencing.
View Article and Find Full Text PDFAnn Epidemiol
May 2018
Registre des cancers du Bas-Rhin, Laboratoire d'Épidémiologie et de Santé Publique, U1113, FMTS, Université de Strasbourg, Strasbourg, France; Service de Santé Publique, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Purpose: To analyze trends in second primary cancer (SPC) incidence by using a case-mix approach to standardize on first cancer site distribution.
Methods: Cases registered by 13 French cancer registries between 1989 and 2010 and followed-up until June 2013 were included. The person-year approach was used to compute standardized incidence ratios (SIRs) of metachronous SPC.
Pediatr Blood Cancer
July 2018
Institut de Pharmacie, Centre Hospitalier Regional Universitaire de Lille, Lille, France.
Pediatr Blood Cancer
July 2018
CHU Lille, Institut de Pharmacie, F-59000, Lille, France.
Background: Etoposide phosphate (EP; single injection, 60 mg/kg) followed by total body irradiation (TBI) at 12 Gy has been used as an allogeneic stem cell transplantation (allo-SCT) conditioning regimen for children since 2010. In our institution, EP has been suspected of leading to acute nephrotoxicity. The aim of this study was to assess the potential renal toxicity of EP in this context.
View Article and Find Full Text PDFJ Gynecol Obstet Hum Reprod
March 2018
Department of Obstetrics and Gynaecology, CHU Bicêtre (centre hospitalier universitaire de Bicêtre [Bicêtre University Hospital Centre]), AP-HP (Assistance Publique-Hôpitaux de Paris [Public Healthcare-Paris Hospitals]), 78, rue du Général-Leclerc, 94270 le Kremlin-Bicêtre, France; University Paris Sud 11 Orsay, 63, rue Gabriel-Péri, 94270 le Kremlin-Bicêtre, France; Inserm U1018, CESP (Centre of Research in Epidemiology and Population Health, 82, rue du Général-Leclerc, 94270 le Kremlin-Bicêtre, France.
Liver Transpl
June 2018
Hôpital Henri Mondor, Créteil, France.
Eur J Endocrinol
May 2018
Department of EndocrinologyAix Marseille Universite, CNRS UMR7286, Assistance Publique-Hopitaux de Marseille, La Conception Hospital, Marseille, France.
Objective: Ketoconazole (KTZ) is one of few available treatments for Cushing's syndrome (CS). Although KTZ has been associated with severe hepatotoxicity, little information is available about hepatic safety in CS. The aim of this study was to document changes in liver function in patients with CS treated with KTZ.
View Article and Find Full Text PDF